deltatrials
Terminated NCT00283530

Tumor Phenotypes and Correlation to Clinical Outcomes in Cancer

Identification of Tumor Phenotypes and Correlation to Clinical Outcomes in Patients Diagnosed With Cancer

Sponsor: Kentuckiana Cancer Institute

Conditions Cancer
Interventions Tumor biopsy
Updated 10 times since 2017 Last updated: Jan 18, 2010 Started: May 31, 2003 Completion: Jul 31, 2009

This observational or N/A phase trial investigates Cancer and is currently terminated or withdrawn. Kentuckiana Cancer Institute leads this study, which shows 10 recorded versions since 2003 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Change History

10 versions recorded
  1. Sep 2024 — Present [monthly]

    Terminated

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated

  3. Dec 2021 — Jul 2024 [monthly]

    Terminated

  4. Jan 2021 — Dec 2021 [monthly]

    Terminated

  5. Nov 2020 — Jan 2021 [monthly]

    Terminated

Show 5 earlier versions
  1. Jun 2018 — Nov 2020 [monthly]

    Terminated

  2. May 2018 — Jun 2018 [monthly]

    Terminated

  3. Apr 2018 — May 2018 [monthly]

    Terminated

    Phase: NANone

  4. Aug 2017 — Apr 2018 [monthly]

    Terminated NA

  5. Jan 2017 — Aug 2017 [monthly]

    Terminated NA

    First recorded

May 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Kentuckiana Cancer Institute
Data source: Kentuckiana Cancer Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • Louisville, United States